2011 Consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology

Billingham, 1990, A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation, J Heart Transplant, 9, 587

Stewart, 2005, Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection, J Heart Lung Transplant, 24, 1710, 10.1016/j.healun.2005.03.019

Parrillo, 1984, The results of transvenous endomyocardial biopsy can frequently be used to diagnose myocardial diseases in patients with idiopathic heart failure. Endomyocardial biopsies in 100 consecutive patients revealed a substantial incidence of myocarditis, Circulation, 69, 93, 10.1161/01.CIR.69.1.93

Arbustini, 1997, Ten-year experience with endomyocardial biopsy in myocarditis presenting with congestive heart failure: frequency, pathologic characteristics, treatment and follow-up, G Ital Cardiol, 27, 209

Veinot, 2002, Diagnostic endomyocardial biopsy pathology—general biopsy considerations, and its use for myocarditis and cardiomyopathy: a review, Can J Cardiol, 18, 55

Leatherbury, 1988, Value of endomyocardial biopsy in infants, children and adolescents with dilated or hypertrophic cardiomyopathy and myocarditis, J Am Coll Cardiol, 12, 1547, 10.1016/S0735-1097(88)80024-X

Mason, 1994, Endomyocardial biopsy and the causes of dilated cardiomyopathy, J Am Coll Cardiol, 23, 591, 10.1016/0735-1097(94)90741-2

Veinot, 2002, Diagnostic endomyocardial biopsy pathology: secondary myocardial diseases and other clinical indications—a review, Can J Cardiol, 18, 287

Basso, 2009, Arrhythmogenic right ventricular cardiomyopathy, Lancet, 373, 1289, 10.1016/S0140-6736(09)60256-7

Corrado, 2008, Three-dimensional electroanatomical voltage mapping and histologic evaluation of myocardial substrate in right ventricular outflow tract tachycardia, J Am Coll Cardiol, 51, 731, 10.1016/j.jacc.2007.11.027

Avella, 2008, Diagnostic value of endomyocardial biopsy guided by electroanatomic voltage mapping in arrhythmogenic right ventricular cardiomyopathy/dysplasia, J Cardiovasc Electrophysiol, 19, 1127, 10.1111/j.1540-8167.2008.01228.x

Basso, 2008, Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy/dysplasia: an in vitro validation of diagnostic criteria, Eur Heart J, 29, 2760, 10.1093/eurheartj/ehn415

Hasegawa, 1990, High incidence of significant pathology in endomyocardial biopsy and familial occurrence in cases with arrhythmia and/or conduction disturbance, Heart Vessels Suppl, 5, 28

Uusimaa, 2008, Ventricular tachyarrhythmia as a primary presentation of sarcoidosis, Europace, 10, 760, 10.1093/europace/eun110

Poletti, 1993, In vivo diagnosis of cardiac angiosarcoma by endomyocardial biopsy, Cardiovasc Pathol, 2, 89, 10.1016/1054-8807(93)90018-W

Basso, 1996, Primary right atrial fibrosarcoma diagnosed by endocardial biopsy, Am Heart J, 131, 399, 10.1016/S0002-8703(96)90374-9

Piccaluga, 2006, Primary cardiac non-Hodgkin lymphoma presenting with atrial flutter and pericardial effusion, Br J Haematol, 134, 356, 10.1111/j.1365-2141.2006.06168.x

Adachi, 1988, Right atrial angiosarcoma diagnosed by cardiac biopsy, Am Heart J, 115, 482, 10.1016/0002-8703(88)90504-2

Hanley, 1983, Intracavitary cardiac melanoma diagnosed by endomyocardial left ventricular biopsy, Chest, 84, 195, 10.1378/chest.84.2.195

Hausheer, 1987, Intracardiac sarcoma diagnosed by left ventricular endomyocardial biopsy, Chest, 92, 177, 10.1378/chest.92.1.177

Flipse, 1990, Diagnosis of malignant cardiac disease by endomyocardial biopsy, Mayo Clin Proc, 65, 1415, 10.1016/S0025-6196(12)62165-X

Felker, 1999, The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients, Medicine, 78, 270, 10.1097/00005792-199907000-00005

Felker, 2000, Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy, N Engl J Med, 342, 1077, 10.1056/NEJM200004133421502

Perkan, 2002, Dilated cardiomyopathy: indication and role of endomyocardial biopsy, Ital Heart J Suppl, 3, 419

Pawlak, 2005, Is diagnostic myocardial biopsy useful in the XXI century?, Kardiol Pol, 62, 360

Leone, 2009, Consensus document on endomyocardial biopsy of the Associazione per la Patologia Cardiovascolare Italiana, G Ital Cardiol, 10, 3S

Thiene, 2010, AECVP and SCVP 2009 recommendations for training in cardiovascular pathology, Cardiovasc Pathol, 19, 129, 10.1016/j.carpath.2009.12.001

Burke, 1991, Serial sectioning and multiple level examination of endomyocardial biopsies for the diagnosis of myocarditis, Mod Pathol, 4, 690

Steenbergen, 1986, Detection of lymphocytes in endomyocardium using immunohistochemical techniques. Relevance to evaluation of endomyocardial biopsies in suspected cases of lymphocytic myocarditis, J Appl Cardiol, 1, 63

Milei, 1990, Immunohistochemical staining of lymphocytes for the reliable diagnosis of myocarditis in endomyocardial biopsies, Cardiology, 77, 77, 10.1159/000174587

Linke, 2006, Classification of amyloidosis: misdiagnosing by way of incomplete immunohistochemistry and how to prevent it, Acta Histochem, 108, 197, 10.1016/j.acthis.2006.03.010

Linke, 1986, Classification of amyloid syndromes from tissue sections using antibodies against various amyloid fibril proteins: report of 142 cases

van de Kaa, 1986, Diagnosis of the type of amyloid in paraffin wax embedded tissue sections using antisera against human and animal amyloid proteins, Virchows Arch [A], 408, 649, 10.1007/BF00705343

Severini, 1993, Nested polymerase chain reaction for high-sensitivity detection of enteroviral RNA in biological samples, J Clin Microbiol, 31, 1345, 10.1128/JCM.31.5.1345-1349.1993

Kuhl, 2005, High prevalence of viral genomes and multiple viral infections in the myocardium of adults with “idiopathic” left ventricular dysfunction, Circulation, 111, 887, 10.1161/01.CIR.0000155616.07901.35

Calabrese, 2003, Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects, Cardiovasc Res, 60, 11, 10.1016/S0008-6363(03)00475-9

Bowles, 2003, Detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause of myocarditis in children and adults, J Am Coll Cardiol, 42, 466, 10.1016/S0735-1097(03)00648-X

Calabrese, 2002, Molecular diagnosis of myocarditis and dilated cardiomyopathy in children: clinicopathologic features and prognostic implications, Diagn Mol Pathol, 11, 212, 10.1097/00019606-200212000-00004

Jay, 1993, Dystrophin analysis in the diagnosis of childhood muscular dystrophy: an immunohistochemical study of 75 cases, Pediatr Pathol, 13, 635, 10.3109/15513819309048251

Maeda, 1995, Cardiac dystrophin abnormalities in Becker muscular dystrophy assessed by endomyocardial biopsy, Am Heart J, 129, 702, 10.1016/0002-8703(95)90319-4

Arbustini, 2000, Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy, J Am Coll Cardiol, 35, 1760, 10.1016/S0735-1097(00)00650-1

Kato, 1992, Fabry's disease, Intern Med, 31, 682, 10.2169/internalmedicine.31.682

Wadskov, 1975, On the diagnosis of Fabry's disease, Acta Derm Venereol, 55, 363, 10.2340/000155555363366

Arbustini, 1998, Restrictive cardiomyopathy, atrioventricular block and mild to subclinical myopathy in patients with desmin-immunoreactive material deposits, J Am Coll Cardiol, 31, 645, 10.1016/S0735-1097(98)00026-6

Arbustini, 2006, Desmin accumulation restrictive cardiomyopathy and atrioventricular block associated with desmin gene defects, Eur J Heart Fail, 8, 477, 10.1016/j.ejheart.2005.11.003

Aretz, 1987, Myocarditis: a histopathologic definition and classification, Am J Cardiovasc Pathol, 1, 3

Edwards, 1985, Current problems in establishing quantitative histopathologic criteria for the diagnosis of lymphocytic myocarditis by endomyocardial biopsy, Heart Vessels Suppl, 1, 138, 10.1007/BF02072381

Billingham, 1989, Acute myocarditis: is sampling error a contraindication for diagnostic biopsies?, J Am Coll Cardiol, 14, 921, 10.1016/0735-1097(89)90466-X

Baandrup, 1982, Do endomyocardial biopsies represent the morphology of the rest of the myocardium? A quantitative light microscopic study of single v. multiple biopsies with the King's bioptome, Eur Heart J, 3, 171, 10.1093/oxfordjournals.eurheartj.a061281

Keogh, 1990, Rapid histological changes in endomyocardial biopsy specimens after myocarditis, Br Heart J, 64, 406, 10.1136/hrt.64.6.406

Sinagra, 1997, Clinical polymorphic presentation and natural history of active myocarditis: experience in 60 cases, G Ital Cardiol, 27, 758

Scott, 1990, The use of combined transoesophageal echocardiography and fluoroscopy in the biopsy of a right atrial mass, Br J Radiol, 63, 222, 10.1259/0007-1285-63-747-222

Savoia, 1997, Transesophageal echocardiography-guided transvenous biopsy of a cardiac sarcoma, J Am Soc Echocardiogr, 10, 752, 10.1016/S0894-7317(97)70120-2

Edwards, 1992, Histological examination of tissues obtained by endomyocardial biopsy, 95

Yilmaz, 2010, Comparative evaluation of left and right ventricular endomyocardial biopsy: differences in complication rate and diagnostic performance, Circulation, 122, 900, 10.1161/CIRCULATIONAHA.109.924167

Mahrholdt, 2004, Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology, Circulation, 109, 1250, 10.1161/01.CIR.0000118493.13323.81

Corrado, 2005, Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia, Circulation, 111, 3042, 10.1161/CIRCULATIONAHA.104.486977

Miller, 1988, Echocardiography-guided endomyocardial biopsy. A 5-year experience, Circulation, 78, III99

Blomstrom-Lundqvist, 1993, Safety of transvenous right ventricular endomyocardial biopsy guided by two-dimensional echocardiography, Clin Cardiol, 16, 487, 10.1002/clc.4960160606

Edwards, 1990, Endomyocardial biopsy and cardiomyopathy, CVR & R, 11, 26

Osterhaus, 1998, Transmission of hepatitis B virus among heart transplant recipients during endomyocardial biopsy procedures, J Heart Lung Transplant, 17, 158

Sekiguchi, 1988, World survey of catheter biopsy of the heart, 217

Holzmann, 2008, Complication rate of right ventricular endomyocardial biopsy via the femoral approach a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period, Circulation, 118, 1722, 10.1161/CIRCULATIONAHA.107.743427

Cooper, 2007, The role of endomyocardial biopsy in the management of cardiovascular disease—a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology, J Am Coll Cardiol, 50, 1914, 10.1016/j.jacc.2007.09.008

Knottnerus, 2002, Evaluation of diagnostic procedures, BMJ, 324, 477, 10.1136/bmj.324.7335.477

Frustaci, 2003, Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders, Circulation, 107, 857, 10.1161/01.CIR.0000048147.15962.31

Kuhl, 2003, Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction, Circulation, 107, 2793, 10.1161/01.CIR.0000072766.67150.51

Daliento, 2003, Successful treatment of enterovirus-induced myocarditis with interferon-alpha, J Heart Lung Transplant, 22, 214, 10.1016/S1053-2498(02)00565-X

Frustaci, 2001, Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy, N Engl J Med, 345, 25, 10.1056/NEJM200107053450104

Falk, 2005, Diagnosis and management of the cardiac amyloidoses, Circulation, 112, 2047, 10.1161/CIRCULATIONAHA.104.489187

Dubrey, 2004, Cardiac transplantation for amyloid heart disease: the United Kingdom experience, J Heart Lung Transplant, 23, 1142, 10.1016/j.healun.2003.08.027

Rapezzi, 2009, Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types, Circulation, 120, 1203, 10.1161/CIRCULATIONAHA.108.843334

Veinot, 2009, Diagnostic endomyocardial biopsy—still useful after all these years, Can J Cardiol, 25, e55, 10.1016/S0828-282X(09)70485-4

Luk, 2007, Do clinical diagnoses correlate with pathological diagnosis in cardiac transplant patients? The importance of endomyocardial biopsy, Can J Cardiol, 25, e48, 10.1016/S0828-282X(09)70484-2

Stone JR, Basso C, Baandrup UT et al. Recommendations for processing cardiovascular surgical pathology specimens: a consensus statement from the Standards and Definitions Committee of the Society for Cardiovascular Pathology and the Association for European Cardiovascular Pathology. Cardiovasc Pathol. In Press.

Baughman, 2006, Diagnosis of myocarditis—death of Dallas criteria, Circulation, 113, 593, 10.1161/CIRCULATIONAHA.105.589663

Aretz, 1987, Myocarditis: a histopathologic definition and classification, Am J Cardiovasc Path, 1, 3

Woodruff, 1998, Viral myocarditis: a review, J Infect, 37, 424

Maisch, 1999, World Heart Foundation consensus conference's definition of inflammatory cardiomyopathy (myocarditis): report from two expert committees on histology and viral cardiomyopathy, Heartbeat, 4, 3

Cooper, 1997, Idiopathic giant-cell myocarditis—natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators, N Engl J Med, 336, 1860, 10.1056/NEJM199706263362603

Leone, 1996, Severe postcardiac-transplant rejection associated with recurrence of giant cell myocarditis, Cardiovasc Pathol, 5, 163, 10.1016/1054-8807(95)00088-7

Fairfax, 1988, Endomyocardial biopsy in patients with systemic lupus erythematosus, J Rheumatol, 15, 593

Salomone, 1989, The role of endomyocardial biopsy in the diagnosis of cardiac involvement in systemic lupus erythematosus, Heart Vessels, 5, 52, 10.1007/BF02058359

Kawai, 1999, From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future, Circulation, 99, 1091, 10.1161/01.CIR.99.8.1091

Badorff, 1999, Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy, Nat Med, 5, 320, 10.1038/6543

Caforio, 2007, A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis, Eur Heart J, 28, 1326, 10.1093/eurheartj/ehm076

Angelini, 2002, Active versus borderline myocarditis: clinicopathological correlates and prognostic implications, Heart, 87, 210, 10.1136/heart.87.3.210

Stewart, 2011, Myocardial parvovirus B19 persistence: lack of association with clinicopathologic phenotype in adults with heart failure, Circ Heart Fail, 4, 71, 10.1161/CIRCHEARTFAILURE.110.958249

Lotze, 2010, Low level myocardial parvovirus B19 persistence is a frequent finding in patients with heart disease but unrelated to ongoing myocardial injury, J Med Virol, 82, 1449, 10.1002/jmv.21821

Calabrese, 2010, Cardiac infections: focus on molecular diagnosis, Cardiovasc Pathol, 19, 171, 10.1016/j.carpath.2009.09.010

Pinkert, 2009, Prevention of cardiac dysfunction in acute coxsackievirus B3 cardiomyopathy by inducible expression of a soluble coxsackievirus-adenovirus receptor, Circulation, 120, 2358, 10.1161/CIRCULATIONAHA.108.845339

Richardson, 1996, Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies, Circulation, 93, 841, 10.1161/01.CIR.93.5.841

Pathak, 1996, Molecular pathology of dilated cardiomyopathies, Curr Probl Cardiol, 21, 97, 10.1016/S0146-2806(96)80012-0

Michels, 1992, The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy, N Engl J Med, 326, 77, 10.1056/NEJM199201093260201

Siu, 1994, Dilated cardiomyopathy, Curr Opin Cardiol, 9, 337, 10.1097/00001573-199405000-00012

Michels, 1993, Histopathology of familial versus nonfamilial dilated cardiomyopathy, Cardiovasc Pathol, 2, 219, 10.1016/1054-8807(93)90027-Y

Limongelli, 2010, Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease, Eur J Heart Fail, 12, 114, 10.1093/eurjhf/hfp186

Taylor, 2003, A homoplasmic mitochondrial transfer ribonucleic acid mutation as a cause of maternally inherited hypertrophic cardiomyopathy, JACC, 41, 1786, 10.1016/S0735-1097(03)00300-0

Pasotti, 2008, Long-term outcome and risk stratification in dilated cardiolaminopathies, J Am Coll Cardiol, 52, 1250, 10.1016/j.jacc.2008.06.044

Cowan, 2010, Morphological analysis of 13 LMNA variants identified in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy, Circ Cardiovasc Genet, 3, 6, 10.1161/CIRCGENETICS.109.905422

Gupta, 2010, Genetic and ultrastructural studies in dilated cardiomyopathy patients: a large deletion in the lamin A/C gene is associated with cardiomyocyte nuclear envelope disruption, Basic Res Cardiol, 105, 365, 10.1007/s00395-010-0085-4

Diercks, 2010, Ultrastructural pathology of the nuclear envelope in familial lamin A/C cardiomyopathy, Cardiovasc Pathol, 19, e135, 10.1016/j.carpath.2009.03.001

Thiene, 1988, Right ventricular cardiomyopathy and sudden death in young people, New Engl J Med, 318, 129, 10.1056/NEJM198801213180301

Nava, 2000, Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy, J Am Coll Cardiol, 36, 2226, 10.1016/S0735-1097(00)00997-9

Marcus, 2010, Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. proposed modification of the task force criteria, Circulation, 121, 1533, 10.1161/CIRCULATIONAHA.108.840827

Asimaki, 2009, A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy, N Engl J Med, 360, 1075, 10.1056/NEJMoa0808138

Wigle, 1995, Hypertrophic cardiomyopathy. Clinical spectrum and treatment, Circulation, 92, 1680, 10.1161/01.CIR.92.7.1680

Marian, 2010, Hypertrophic cardiomyopathy: from genetics to treatment, Eur J Clin Invest, 40, 360, 10.1111/j.1365-2362.2010.02268.x

Frustaci, 2002, The role of endomyocardial biopsy in the diagnosis of cardiomyopathies, Ital Heart J, 3, 348

Schoenfeld, 1987, Restrictive cardiomyopathy versus constrictive pericarditis: role of endomyocardial biopsy in avoiding unnecessary thoracotomy, Circulation, 75, 1012, 10.1161/01.CIR.75.5.1012

Hosenpud, 1986, Clinical, hemodynamic and endomyocardial biopsy findings in idiopathic restrictive cardiomyopathy, West J Med, 144, 303

Ogbogu, 2007, Cardiovascular manifestations of hypereosinophilic syndromes, Immunol Allergy Clin North Am, 27, 457, 10.1016/j.iac.2007.07.001

Fauci, 1982, NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations, Ann Intern Med, 97, 78, 10.7326/0003-4819-97-1-78

Bukhman, 2008, Endomyocardial fibrosis: still a mystery after 60 years, PLoS Negl Trop Dis, 2, e97, 10.1371/journal.pntd.0000097

Arnold, 1988, Loeffler's fibroplastic endocarditis, Pathology, 20, 79, 10.3109/00313028809085205

Iglezias, 2008, Endomyocardial fibrosis: pathological and molecular findings of surgically resected ventricular endomyocardium, Virchows Arch, 453, 233, 10.1007/s00428-008-0652-3

Ladyjanskaia, 2010, Sarcoid myocarditis with ventricular tachycardia mimicking ARVD/C, J Cardiovasc Electrophysiol, 21, 94, 10.1111/j.1540-8167.2009.01479.x

Vasaiwala, 2009, Prospective study of cardiac sarcoid mimicking arrhythmogenic right ventricular dysplasia, J Cardiovasc Electrophysiol, 20, 473, 10.1111/j.1540-8167.2008.01351.x

Corrado, 2009, Cardiac sarcoidosis mimicking arrhythmogenic right ventricular cardiomyopathy/dysplasia: the renaissance of endomyocardial biopsy?, J Cardiovasc Electrophysiol, 20, 477, 10.1111/j.1540-8167.2008.01387.x

Uemura, 1999, Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies, Am Heart J, 138, 299, 10.1016/S0002-8703(99)70115-8

Ardehali, 2005, A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy, Am Heart J, 150, 459, 10.1016/j.ahj.2004.10.006

Felker, 2000, Myocarditis and long-term survival in peripartum cardiomyopathy, Am Heart J, 140, 785, 10.1067/mhj.2000.110091

Lamparter, 2007, Clinical and immunologic characteristics in peripartum cardiomyopathy, Int J Cardiol, 118, 14, 10.1016/j.ijcard.2006.04.090

Collins, 2009, Classification of amyloid deposits in diagnostic cardiac specimens by immunofluorescence, Cardiovasc Pathol, 18, 205, 10.1016/j.carpath.2008.05.004

Crotty, 1995, Amyloidosis and endomyocardial biopsy: correlation of extent and pattern of deposition with amyloid immunophenotype in 100 cases, Cardiovasc Pathol, 4, 39, 10.1016/1054-8807(94)00023-K

Arbustini, 1997, Light and electron microscopy immunohistochemical characterization of amyloid deposits, Amyloid, 4, 157, 10.3109/13506129709014380

Benson, 2009, Biochemical characterisation of amyloid by endomyocardial biopsy, Amyloid, 16, 9, 10.1080/13506120802676914

Vrana, 2009, Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens, Blood, 114, 4957, 10.1182/blood-2009-07-230722

Kremastinos, 2010, Beta-thalassemia cardiomyopathy: history, present considerations, and future perspectives, Circ Heart Fail, 3, 451, 10.1161/CIRCHEARTFAILURE.109.913863

Pietrangelo, 2004, Hereditary hemochromatosis—a new look at an old disease, N Engl J Med, 350, 2383, 10.1056/NEJMra031573

Lombardo, 1995, Cardiac iron overload in thalassemic patients: an endomyocardial biopsy study, Ann Hematol, 71, 135, 10.1007/BF01702649

Wood, 2007, Diagnosis and management of transfusion iron overload: the role of imaging, Am J Hematol, 82, 1132, 10.1002/ajh.21099

Mavrogeni, 2005, A comparison of magnetic resonance imaging and cardiac biopsy in the evaluation of heart iron overload in patients with beta-thalassemia major, Eur J Haematol, 75, 241, 10.1111/j.1600-0609.2005.00474.x

Olson, 1987, Cardiac iron deposition in idiopathic hemochromatosis: histologic and analytic assessment of 14 hearts from autopsy, J Am Coll Cardiol, 10, 1239, 10.1016/S0735-1097(87)80124-9

Dalakas, 2000, Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene, N Engl J Med, 342, 770, 10.1056/NEJM200003163421104

van Tintelen, 2009, Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene, Heart Rhythm, 6, 1574, 10.1016/j.hrthm.2009.07.041

Otten, 2010, Desmin mutations as a cause of right ventricular heart failure affect the intercalated disks, Heart Rhythm, 7, 1058, 10.1016/j.hrthm.2010.04.023

Mehta, 2004, Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey, Eur J Clin Invest, 34, 236, 10.1111/j.1365-2362.2004.01309.x

Thurberg, 2009, Cardiac microvascular pathology in Fabry disease: evaluation of endomyocardial biopsies before and after enzyme replacement therapy, Circulation, 119, 2561, 10.1161/CIRCULATIONAHA.108.841494

Schmaltz, 1990, Endomyocardial biopsy in infants and children: experience in 60 patients, Pediatr Cardiol, 11, 15, 10.1007/BF02239542

Ben-Ami, 2001, The Mount Sinai Hospital clinical–pathological conference: a 45-year-old man with Pompe's disease and dilated cardiomyopathy, Mt Sinai J Med, 68, 205

Rohrbach, 2007, Treatment of lysosomal storage disorders: progress with enzyme replacement therapy, Drugs, 67, 2697, 10.2165/00003495-200767180-00005

Staretz-Chacham, 2009, Lysosomal storage disorders in the newborn, Pediatrics, 123, 1191, 10.1542/peds.2008-0635

Thiene, 2009, Tumours of the heart, 735

Roberts, 1997, Primary and secondary neoplasms of the heart, Am J Cardiol, 80, 671, 10.1016/S0002-9149(97)00587-0

Burke, 1996

Bussani, 2007, Cardiac metastases, J Clin Pathol, 60, 27, 10.1136/jcp.2005.035105

Burke, 2004, Tumours of the heart

Basso, 1997, Surgical pathology of primary cardiac and pericardial tumors, Eur J Cardiothorac Surg, 12, 730, 10.1016/S1010-7940(97)00246-7

Burke, 2008, Primary malignant cardiac tumors, Semin Diagn Pathol, 25, 39, 10.1053/j.semdp.2007.10.006

Fletcher, 2002, WHO classification of tumours

Burke, 2008, Pediatric heart tumors, Cardiovasc Pathol, 17, 193, 10.1016/j.carpath.2007.08.008

Becker, 2000, Primary heart tumors in the pediatric age group: a review of salient pathologic features relevant for clinicians, Pediatr Cardiol, 21, 317, 10.1007/s002460010071

Isaacs, 2004, Fetal and neonatal cardiac tumors, Pediatr Cardiol, 25, 252, 10.1007/s00246-003-0590-4

Chan, 2001, Diagnosis of left atrial sarcoma by transvenous endocardial biopsy, Can J Cardiol, 17, 206

Alter, 2001, Diagnosis of primary cardiac lymphoma by endomyocardial biopsy, Am J Med, 110, 593, 10.1016/S0002-9343(01)00662-3

Burling, 2000, Primary cardiac lymphoma diagnosed with transesophageal echocardiography-guided endomyocardial biopsy, Circulation, 101, E179, 10.1161/01.CIR.101.17.e179

Hosokawa, 2010, Cardiac angiosarcoma diagnosed by transvenous endomyocardial biopsy with the aid of transesophageal echocardiography and intra-procedural consultation, Int Heart J, 51, 367, 10.1536/ihj.51.367

Miller, 2010, Cardiac metastasis from poorly differentiated carcinoma of the cervix: a case report, J Reprod Med, 55, 78

Fuzellier, 2005, Primary cardiac lymphoma: diagnosis and treatment. Report of 6 cases and review of the literature, Arch Mal Coeur Vaiss, 98, 875

Takach, 1996, Primary cardiac tumors in infants and children: immediate and long-term operative results, Ann Thorac Surg, 62, 559, 10.1016/0003-4975(96)00349-9

Gelb, 1993, Infantile histiocytoid cardiomyopathy—myocardial or conduction system hamartoma: what is the cell type involved?, Hum Pathol, 24, 1226, 10.1016/0046-8177(93)90219-7

Fealey, 2008, Hamartomas of mature cardiac myocytes: report of 7 new cases and review of literature, Hum Pathol, 39, 1064, 10.1016/j.humpath.2007.11.014

Salka, 1993, Transvenous biopsy of intracardiac tumor under transesophageal echocardiographic guidance, Am Heart J, 125, 1782, 10.1016/0002-8703(93)90776-6

Nardi, 1999, Percutaneous transvenous biopsy for the diagnosis of a right atrial myxoma, G Ital Cardiol, 29, 308

Bittira, 2000, Primary right atrial synovial sarcoma manifesting as transient ischemic attacks, Ann Thorac Surg, 69, 1949, 10.1016/S0003-4975(00)01283-2

Amory, 1996, Diagnosis of primary cardiac leiomyosarcoma by endomyocardial biopsy, Cardiovasc Pathol, 5, 113, 10.1016/1054-8807(95)00060-7

Vujin, 2006, Rhabdomyosarcoma of the heart, Herz, 31, 798, 10.1007/s00059-006-2770-5

Mignano, 2009, Intracardiac chloroma, J Pediatr Hematol Oncol, 31, 977, 10.1097/MPH.0b013e3181b78951

Owa, 2000, Primary cardiac malignant fibrous histiocytoma in the right ventricular infundibulum treated with a cavo-pulmonary shunt and coronary embolization, Jpn Circ J, 64, 982, 10.1253/jcj.64.982

Butany, 2005, Cardiac tumours: diagnosis and management, Lancet Oncol, 6, 219, 10.1016/S1470-2045(05)70093-0

Testolin, 2001, Cardiogenic shock due to metastatic cardiac lymphoma: still a diagnostic and therapeutic challenge, Eur J Cardiothorac Surg, 19, 365, 10.1016/S1010-7940(01)00578-4

Chin, 2009, Extensive primary cardiac lymphoma diagnosed by percutaneous endomyocardial biopsy, J Cardiovasc Ultrasound, 17, 141, 10.4250/jcu.2009.17.4.141

Jaffe, 2001

Jain, 2010, Molecular classification of soft tissue sarcomas and its clinical applications, Int J Clin Exp Pathol, 3, 416

Monsuez, 2010, Cardiac side-effects of cancer chemotherapy, Int J Cardiol, 144, 3, 10.1016/j.ijcard.2010.03.003

Butany, 2009, Drug-related cardiac pathology, J Clin Pathol, 62, 1074, 10.1136/jcp.2008.058255

Lewis, 2001, Adverse effects of drugs in the cardiovascular system, 541

Ewer, 2005, Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment, J Clin Oncol, 23, 7820, 10.1200/JCO.2005.13.300

Telli, 2007, Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility, J Clin Oncol, 25, 3525, 10.1200/JCO.2007.11.0106

Bristow, 1981, Dose–effect and structure–function relationships in doxorubicin cardiomyopathy, Am Heart J, 102, 709, 10.1016/0002-8703(81)90096-X

Lipshultz, 1991, Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood, N Engl J Med, 324, 808, 10.1056/NEJM199103213241205

Telli, 2008, Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate, Ann Oncol, 19, 1613, 10.1093/annonc/mdn168

Kappers, 2009, Cardiovascular and renal toxicity during angiogenesis inhibition: clinical and mechanistic aspects, J Hypertens, 27, 2297, 10.1097/HJH.0b013e3283309b59

Chu, 2007, Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib, Lancet, 370, 2011, 10.1016/S0140-6736(07)61865-0

Connolly, 1997, Valvular heart disease associated with fenfluramine-phentermine, N Engl J Med, 337, 581, 10.1056/NEJM199708283370901

Noize, 2006, Valvular heart disease in a patient taking benfluorex, Fundam Clin Pharmacol, 20, 577, 10.1111/j.1472-8206.2006.00441.x

Antonini, 2007, Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease, Lancet Neurol, 6, 826, 10.1016/S1474-4422(07)70218-1

Phillips, 2009, Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options, Am J Cardiovasc Drugs, 9, 177, 10.1007/BF03256574

Karch, 1988, The pathology and etiology of cocaine-induced heart disease, Arch Pathol Lab Med, 112, 225

Altena, 2009, Cardiovascular toxicity caused by cancer treatment: strategies for early detection, Lancet Oncol, 10, 391, 10.1016/S1470-2045(09)70042-7

Taniguchi, 2005, Clinical significance of cyclophosphamide-induced cardiotoxicity, Intern Med, 44, 89, 10.2169/internalmedicine.44.89

Billingham, 1978, Anthracycline cardiomyopathy monitored by morphologic changes, Cancer Treat Rep, 62, 865

Yeoh, 1992, Clinical significance of mild rejection of the cardiac allograft, Circulation, 86, II267

Lloveras, 1992, Evolution of untreated mild rejection in heart transplant recipients, J Heart Lung Transplant, 11, 751

Nielsen, 1993, Reproducibility of the acute rejection diagnosis in human cardiac allografts. The Stanford Classification and the International Grading System, J Heart Lung Transplant, 12, 239

Rizeq, 1994, Acute rejection: significance of elapsed time after transplantation, J Heart Lung Transplant, 13, 862

Fishbein, 1994, Grade 2 cellular heart rejection: does it exist?, J Heart Lung Transplant, 13, 1051

Winters, 1995, Natural history of focal moderate cardiac allograft rejection. Is treatment warranted?, Circulation, 91, 1975, 10.1161/01.CIR.91.7.1975

Anguita, 1995, Repetitive nontreated episodes of grade 1B or 2 acute rejection impair long-term cardiac graft function, J Heart Lung Transplant, 14, 452

Milano, 1996, Evolution of focal moderate (International Society for Heart and Lung Transplantation grade 2) rejection of the cardiac allograft, J Heart Lung Transplant, 15, 456

Brunner-La Rocca, 1996, Natural course of moderate cardiac allograft rejection (International Society for Heart Transplantation grade 2) early and late after transplantation, Circulation, 94, 1334, 10.1161/01.CIR.94.6.1334

Winters, 1996, Consistencies and controversies in the application of the International Society for Heart and Lung Transplantation working formulation for heart transplant biopsy specimens. Rapamycin Cardiac Rejection Treatment Trial Pathologists, J Heart Lung Transplant, 15, 728

Winters, 1997, The challenge of endomyocardial biopsy interpretation in assessing cardiac allograft rejection, Curr Opin Cardiol, 12, 146, 10.1097/00001573-199703000-00009

Winters, 1998, The International Society for Heart and Lung Transplantation grading system for heart transplant biopsy specimens: clarification and commentary, J Heart Lung Transplant, 17, 754

Marboe, 2005, Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT grade 2 and 3A rejection in cardiac allograft recipients, J Heart Lung Transplant, 24, S219, 10.1016/j.healun.2005.04.001

Hammond, 1989, Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications, J Heart Transplant, 8, 430

Hammond, 2001, Vascular rejection in cardiac transplantation: histologic, immunopathologic, and ultrastructural features, Cardiovasc Pathol, 10, 21

Lones, 1995, Clinical–pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients, J Heart Lung Transplant, 14, 151

Michaels, 2003, Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease, J Heart Lung Transplant, 22, 58, 10.1016/S1053-2498(02)00472-2

Kfoury, 2009, A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in heart transplantation, J Heart Lung Transplant, 28, 51, 10.1016/j.healun.2008.09.012

Reed, 2006, Acute antibody-mediated rejection of cardiac transplants, J Heart Lung Transplant, 25, 153, 10.1016/j.healun.2005.09.003

Wu, 2009, Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes, J Heart Lung Transplant, 28, 417, 10.1016/j.healun.2009.01.015

Hammond, 2005, Utility of histologic parameters in screening for antibody-mediated rejection of the cardiac allograft: a study of 3,170 biopsies, J Heart Lung Transplant, 24, 2015, 10.1016/j.healun.2005.08.014

Angelini, 2010, J Heart Lung Transplant, 29, S76, 10.1016/j.healun.2009.11.231

Sis, 2010, Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection, Curr Opin Organ Transplant, 15, 42, 10.1097/MOT.0b013e3283352a50

Tan, 2009, Correlation of donor-specific antibodies, complement and its regulators with graft dysfunction in cardiac antibody-mediated rejection, Am J Transplant, 9, 2075, 10.1111/j.1600-6143.2009.02748.x

Fedrigo, 2010, Can C4d immunostaining on endomyocardial biopsies be considered a prognostic biomarker in heart transplant recipients?, Transplantation, 90, 791, 10.1097/TP.0b013e3181efd059

Moseley, 2010, Deposition of C4d and C3d in cardiac transplants: a factor in the development of coronary artery vasculopathy, J Heart Lung Transplant, 29, 417, 10.1016/j.healun.2009.12.018

Behr, 1999, Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies, J Heart Lung Transplant, 18, 904, 10.1016/S1053-2498(99)00043-1

Chantranuwat, 2004, Immunoperoxidase staining for C4d on paraffin-embedded tissue in cardiac allograft endomyocardial biopsies: comparison to frozen tissue immunofluorescence, Appl Immunohistochem Mol Morphol, 12, 166, 10.1097/00129039-200406000-00012

Fedson, 2008, Immunohistochemistry staining of C4d to diagnose antibody-mediated rejection in cardiac transplantation, J Heart Lung Transplant, 27, 372, 10.1016/j.healun.2008.01.003

Berry, 2011, The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005-2011), J Heart Lung Transplant, 30, 601, 10.1016/j.healun.2011.02.015

Kobashigawa, 2011, Report from a consensus conference on antibody-mediated rejection in heart transplantation, J Heart Lung Transplant, 30, 252, 10.1016/j.healun.2010.11.003

Takemoto, 2004, National conference to assess antibody-mediated rejection in solid organ transplantation, Am J Transplant, 4, 1033, 10.1111/j.1600-6143.2004.00500.x

Gaudin, 1994, Peritransplant injury to the myocardium associated with the development of accelerated arteriosclerosis in heart transplant recipients, Am J Surg Pathol, 18, 338, 10.1097/00000478-199404000-00002

Fyfe, 1996, Heart transplantation-associated perioperative ischemic myocardial injury. Morphological features and clinical significance, Circulation, 93, 1133, 10.1161/01.CIR.93.6.1133

Clausell, 2001, Myocardial vacuolization, a marker of ischemic injury, in surveillance cardiac biopsies posttransplant: correlations with morphologic vascular disease and endothelial dysfunction, Cardiovasc Pathol, 10, 29

Winters, 1997, Graft arteriosclerosis-induced myocardial pathology in heart transplant recipients: predictive value of endomyocardial biopsy, J Heart Lung Transplant, 16, 985

Kottke-Marchant, 1989, Endomyocardial lymphocytic infiltrates in cardiac transplant recipients. Incidence and characterization, Arch Pathol Lab Med, 113, 690

Radio, 1991, Preferential endocardial residence of B-cells in the “Quilty effect” of human heart allografts: immunohistochemical distinction from rejection, Mod Pathol, 4, 654

Joshi, 1995, “Quilty” revisited: a 10-year perspective, Hum Pathol, 26, 547, 10.1016/0046-8177(95)90252-X

Michaels, 2001, Differential expression of RANTES chemokine, TGF-beta, and leukocyte phenotype in acute cellular rejection and quilty B lesions, J Heart Lung Transplant, 20, 407, 10.1016/S1053-2498(00)00318-1

Chu, 2005, The relationship of nodular endocardial infiltrates (Quilty lesions) to survival, patient age, anti-HLA antibodies, and coronary artery disease following heart transplantation, Cardiovasc Pathol, 14, 219, 10.1016/j.carpath.2005.03.009

Taylor, 2009, Registry of the international society for heart and lung transplantation: twenty-sixth official adult heart transplant report—2009, J Heart Lung Transplant, 28, 1007, 10.1016/j.healun.2009.08.014

Hunt, 2008, The changing face of heart transplantation, J Am Coll Cardiol, 52, 587, 10.1016/j.jacc.2008.05.020

Spiegelhalter, 1983, An analysis of repeated biopsies following cardiac transplantation, Stat Med, 2, 33, 10.1002/sim.4780020105

Zerbe, 1988, Diagnostic reliability of endomyocardial biopsy for assessment of cardiac allograft rejection, Hum Pathol, 19, 1307, 10.1016/S0046-8177(88)80286-7

Baraldi-Junkins, 1993, Complications of endomyocardial biopsy in heart transplant patients, J Heart Lung Transplant, 12, 63

Pham, 2010, Gene-expression profiling for rejection surveillance after cardiac transplantation, N Engl J Med, 362, 1890, 10.1056/NEJMoa0912965

Jarcho, 2010, Fear of rejection—monitoring the heart-transplant recipient, N Engl J Med, 362, 1932, 10.1056/NEJMe1004355

Aull, 2004, Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor Registry, Transplantation, 78, 1676, 10.1097/01.TP.0000144333.19106.58

Ziarkiewicz-Wroblewska, 2006, Posttransplant lymphoproliferative disorder: morphological picture and diagnostic difficulties, Transplant Proc, 38, 168, 10.1016/j.transproceed.2005.12.072